Ovarian cancer: a solid tumor with evidence of normal cellular immune function but abnormal B cell function

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Epithelial ovarian cancer (EOC) is a leading cause of cancer death in women.
• Immune system dysregulation is implicated in cancer progression.
• Understanding immune function in untreated EOC is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the immunologic status of B and T lymphocytes in patients with epithelial ovarian cancer before treatment.
• To compare immune function between untreated EOC patients and age-matched healthy controls.

Main Methods:

• Conducted immunologic assays on 21 untreated EOC patients and 12 healthy controls.
• Assessed T cell functions including lymphocyte counts, E rosette positivity, phytohemagglutinin (PHA) and concanavalin A (Con A) stimulation, and skin tests.
• Evaluated B cell functions including surface immunoglobulin expression, pokeweed mitogen (PWM) response, and primary antibody response to keyhole limpet hemocyanin (KLH).

Main Results:

• No significant differences were observed in T cell functions between EOC patients and controls.
• EOC patients showed a statistically significant reduction in surface immunoglobulin-positive cells.
• Patients with EOC demonstrated impaired proliferative response to pokeweed mitogen and a reduced primary antibody response to keyhole limpet hemocyanin.

Conclusions:

• Untreated epithelial ovarian cancer patients possess normal cellular immune function.
• These patients exhibit abnormal B cell function, characterized by reduced immunoglobulin expression and impaired responses to mitogens and antigens.
• These findings suggest a specific immune dysregulation pattern in EOC distinct from other solid tumors.